If you look at my posts on the RVNC thread during the past two or three years, I’m sure you’ll come to the conclusion that many investors at IHub just don’t know what they don’t know.
The same could be said of several investors that I thought were quite experienced and just misinformed. It made no difference
They didn’t give the AbbVie( former Allergan) marketing and sales team any credit whatsoever for their ability to protect their market even though they had successfully defended it against other competitors.
Some of the more fervent perma-bullls stubbornly held onto the belief that the product was so good that they could capture a massive majority market chair, even if they charged premium prices and didn’t properly train the injectors prior to trying to roll out the product
They ignored the company, repeatedly, warning that they doubted their ability to continue as a going concern and continued to have incredible expectations.
Even a couple, highly respected, very competent and experienced investors held onto the belief that this company would make everybody extraordinarily wealthy. … Right up to the very end.
The Case Study you’re looking for already exists and can be looked at in the Revance thread.
However, I’m now convinced that any effort to try and help these less experienced investors avoid losing money is another waste of time the only way they’ll learn their lesson is after they’ve lost more money than they can afford to lose no one will be able to tell them any different or show them a better way they have to learn for themselves, regardless of the cost
AI
Market Data 
Markets 
